EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 155 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 6.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,143,377 | +296.7% | 476,250 | +842.5% | 0.03% | +366.7% |
| Q1 2024 | $1,044,513 | -16.3% | 50,533 | -6.5% | 0.01% | -25.0% |
| Q4 2023 | $1,248,448 | +15.6% | 54,022 | -60.0% | 0.01% | 0.0% |
| Q3 2023 | $1,079,920 | +263.2% | 135,159 | +295.4% | 0.01% | +300.0% |
| Q2 2023 | $297,357 | +614.8% | 34,179 | +187.6% | 0.00% | – |
| Q4 2022 | $41,601 | -56.7% | 11,886 | -2.2% | 0.00% | -100.0% |
| Q3 2022 | $96,000 | +84.6% | 12,152 | +84.1% | 0.00% | – |
| Q2 2022 | $52,000 | -5.5% | 6,600 | +46.6% | 0.00% | – |
| Q1 2022 | $55,000 | -41.5% | 4,501 | -41.6% | 0.00% | -100.0% |
| Q4 2021 | $94,000 | -52.0% | 7,709 | -59.9% | 0.00% | -66.7% |
| Q1 2021 | $196,000 | – | 19,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $42,580,000 | 6.66% |
| Stonepine Capital Management, LLC | 329,130 | $3,344,000 | 1.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $3,048,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 381,145 | $3,872,000 | 1.40% |
| Samsara BioCapital, LLC | 450,000 | $4,572,000 | 0.84% |
| Altium Capital Management LP | 289,316 | $2,939,000 | 0.82% |
| VR Adviser, LLC | 700,000 | $7,112,000 | 0.77% |
| Corriente Advisors, LLC | 200,000 | $2,032,000 | 0.75% |
| RA Capital Management | 1,250,000 | $12,700,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,181,200 | $12,001,000 | 0.18% |